Background and Purpose: The intranasal administration of oxytocin (OT)
reduces migraine headaches through activation of the oxytocin receptor
(OTR). Magnesium ion (Mg2+) concentration is critical to activation of
OTR, and low serum Mg2+ concentration is predictive of migraine
headache. We, therefore, examined the functional impact of Mg2+
concentration on OT-OTR binding efficacy using three complimentary
bioassays. Experimental Approach: Bioluminescence resonance energy
transfer assay was used to investigate the impact of Mg2+ on G-protein
activation secondary to OT-OTR binding. Current clamp recordings of rat
trigeminal ganglia neurons (TG) measured the impact of Mg2+ on
OT-induced reduction in excitability. Finally, we assessed the impact of
Mg2+ on intranasal OT-induced craniofacial analgesia in rats. Key
Results: Mg2+ is an essential cofactor for full OT-OTR agonism and
concentration-dependently increased Gq and G11 activation in
OTR-transfected HEK cells, although OT-OTR binding did not reach maximal
efficacy at physiologic concentrations. OT alone dose-dependently
hyperpolarized TG neurons, decreasing their excitability; the addition
of 1.75mM Mg2+ significantly enhanced this effect. Finally, while
intranasal application of OT produced dose-dependent craniofacial
analgesia; Mg2+ significantly enhanced these effects. Conclusion and
Implications: Mg2+ concentration is critical to OT-OTR signaling, and OT
efficacy may be limited by low ambient Mg2+ levels. The addition of Mg2+
to OT formulations may improve its efficacy in reducing headache pain as
well as for other oxytocin-dependent processes.